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The hormone relaxin is important in female reproduction for embryo implantation,
cardiovascular function, and during labor and lactation. Relaxin is also synthesized in
males by organs of the male tract. We hypothesized that relaxin might be one component
of seminal plasma responsible for eliciting the female cytokine response induced in the
uterus at mating. When recombinant relaxin was injected into the uterus of wild-type
(Rln+/+) mice at estrus, it evoked the production of Cxcl1mRNA and its secreted protein
product CXCL1 in four of eight animals. Mating experiments were then conducted using
mice with a null mutation in the relaxin gene (Rln−/− mice). qRT-PCR analysis of mRNA
expression in wild-type females showed diminished uterine expression of several cytokine
and chemokine genes in the absence of male relaxin. Similar differences were also
noted comparing Rln−/− and Rln+/+ females mated to wild-type males. Quantification of
uterine luminal fluid cytokine content confirmed that male relaxin provokes the production
of CXCL10 and CSF3 in Rln+/+ females. Differences were also seen comparing Rln−/−
and Rln+/+ females mated with Rln−/− males for CXCL1, CSF3, and CCL5, implying
that endogenous relaxin in females might prime the uterus to respond appropriately to
seminal fluid at coitus. Finally, pan-leukocyte CD45 mRNA was increased in wild-type
matings compared to other combinations, implying that male and female relaxin may
trigger leukocyte expansion in the uterus. We conclude that male and/or female relaxin
may be important in activating the uterine cytokine/chemokine network required to initiate
maternal immune adaptation to pregnancy.
Keywords: seminal relaxin, cytokines, endometrium
INTRODUCTION
In the female mammal the peptide hormone relaxin is secreted into the circulation principally from
the ovary and, during pregnancy, probably also from the endometrium and placenta (Sherwood,
1994; Ivell and Einspanier, 2002). It may also be expressed as a paracrine hormone in some
organs, including the heart (Taylor and Clark, 1994). Its principal functions in the context
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of female reproductive physiology are associated with ovulation
(Brannström and MacLennan, 1993), implantation and
endometrial decidualization (Ivell and Einspanier, 2002; Bartsch
et al., 2004), placental growth and angiogenesis (Parry and
Vodstrcil, 2007; Einspanier et al., 2009), myometrial quiescence
in some species associated particularly with term of pregnancy
(Downing and Sherwood, 1985; MacLennan et al., 1986), but also
with spacing of embryos in multiparous rodents (Rogers et al.,
1983). More recently, attention has focused on the role of relaxin
in cardiovascular physiology both during pregnancy and in the
non-pregnant state, where it appears to act in a vasodilatory role
and to reduce arterial resistance (Conrad, 2011). Exogenously
applied relaxin appears to be beneficial for patients suffering
acute heart failure (Ponikowski et al., 2012).
Far less is known about relaxin in the male (summarized
in Ivell et al., 2011), except that it appears to be produced
in moderate amounts by the prostate gland in several species
(Gunnersen et al., 1995; Samuel et al., 2003), and in some
also within the seminal vesicles (Kohsaka et al., 1992). In
terms of functionality in the male, paracrine roles have been
suggested within the prostate gland and in the context of prostate
carcinoma (Ivell et al., 2011). There is also now some evidence
to suggest that relaxin may act directly on spermatozoa, thereby
improving fertilization rates, at least in vitro (Miah et al., 2006;
Ferlin et al., 2012).
For a number of years it has been known that relaxin can
act on the human monocytic cell-line, THP1 (Parsell et al.,
1996; Anand-Ivell et al., 2007), and also on primary decidual
macrophages (Horton et al., 2011), as well as macrophages
produced by differentiating THP1 cells in vitro using phorbol-
myristate-acetate (Anand-Ivell and Ivell, 2014). Additionally,
there are studies suggesting a specific role of relaxin on uterine
lymphocytes (Piccinni et al., 1999, 2000). Relaxin may also act
on cervical cells as well as on the term amniotic membrane,
partly to cause the stimulation and secretion of some cytokines
(Millar et al., 2003; Horton et al., 2011), which may assist in
the birth process and peripartal recovery. Thus, relaxin may
have functional properties which influence the immune response,
though a systematic study of an immunological role for relaxin is
lacking.
There is growing evidence to suggest that during copulation,
besides spermatozoa, seminal plasma also delivers a range of
signaling molecules into the female tract (Robertson et al., 2006;
Robertson, 2007; Bromfield, 2014). One of the most important
of these is TGFβ (Sharkey et al., 2012a), though other molecules,
including prostaglandins are likely to be involved. The main role
for such seminal plasma components appears to be to elicit an
appropriate immunological response in the uterus so that on
the one hand unsuccessful sperm can be quickly removed by
phagocytosis, but also that newly formed semi-allogenic embryos
are not rejected by the maternal immune system (Robertson,
2007, 2010). This immune response is initiated when uterine
epithelial cells respond to TGFβ and other active signaling factors
in semen to upregulate expression of several cytokines and
chemokines (Robertson et al., 1992, 1998). In turn, these recruit
macrophages, granulocytes, and dendritic cells (Kachkache et al.,
1991;McMaster et al., 1992) which then activate regulatory T cells
to mediate maternal immune tolerance at the time of embryo
implantation (Johansson et al., 2004; Robertson et al., 2009).
The components of seminal plasma are mostly generated by
the epithelia of the prostate gland and/or the seminal vesicles,
though some molecules will also be transported from the
epididymis and testis. Relaxin has been shown to be present
in moderate concentration (0.2–2.0 nM) in the seminal plasma
of most mammals (Ivell et al., 2011). Relaxin immunoreactivity
as well as evidence for the presence of the specific relaxin
receptor, RXFP1, also suggest the possibility that relaxin may be
additionally present on spermatozoa (Carrell et al., 1995; Feugang
et al., 2015; Almeida et al., 2016). However, it remains to be
determined whether relaxin of male origin has the capacity to
influence uterine function at the time of insemination. Here we
have employed twomousemodels to evaluate this. Firstly, estrous
virgin wild-type female mice received human recombinant
relaxin or vehicle by injection into the exteriorized dorsal horns
of the non-pregnant uterus, with uterine tissue as well as luminal
lavage fluid being collected shortly thereafter and analyzed.
Secondly, we usedmice with a null mutation in the gene encoding
relaxin (Rln−/−mice) to devise controlledmatings between wild-
type and homozygous null mutant males and females in all
combinations, followed again by analysis of uterine tissue and
uterine fluid lavage. There is no a priori evidence to suggest any
implantation defect in these mice and litter sizes appear normal
(Zhao et al., 1999). The results of these experimental approaches
strongly suggest that relaxin of male (and also female) origin
has a significant effect in the female reproductive tract, eliciting
uterine production of pro-inflammatory cytokines at the time of
insemination and fertilization.
MATERIALS AND METHODS
Animals and Treatments
Experimental mice were generated from breeding pairs
heterozygous for the Rln null mutation (Rln+/− mice) at the
University of Adelaide from founders generously provided by
Dr. Chrishan Samuel (Melbourne, Australia), as previously
described in Zhao et al. (1999). All mice were genotyped as
Rln−/−, Rln+/−, or Rln+/+ from tail clip DNA extracted by
the method of Laird et al. (1991), using the PCR primers and
conditions as described (Zhao et al., 1999).
In the first experiment, wild type (Rln+/+) adult (8–12 weeks)
virgin female mice in estrus were identified by daily vaginal
smearing (Snell, 1941). Mice were anesthetized with isoflurane,
and each uterine horn exteriorized dorsally through an incision
in the body wall. Using an insulin syringe, 15 µl of either vehicle
alone (RPMI with 0.1% BSA) or vehicle plus 25 ng human
recombinant relaxin (rhRLN; a generous gift from Professor John
Wade, Melbourne; this peptide was prepared and validated as
in Stults et al. (1990) and shown by mass spectrometry to be
>98% pure) were injected successively into each uterine horn,
before replacing the tract, clipping the wound, and allowing
recovery on a heated pad. rhRLN has been shown to have
full bioactivity with even slightly lower EC50 compared to rat
relaxin in a mouse RXFP1 receptor bioassay (Scott et al., 2004),
having high homology in those domains responsible for receptor
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binding (Bathgate et al., 2006). Thus, altogether relaxin-treated
mice received a total of 50 ng rhRLN in 30 µl vehicle per
uterus, equivalent to∼270 nMwhich, accounting for degradation
and dilution, should still be more than sufficient to activate
murine RXFP1 receptors (EC50 ca 1 nM; Samuel et al., 2007).
Although mouse seminal relaxin concentration is not known,
data from other species suggest a seminal concentration of∼0.2–
2 nM (Ivell et al., 2011). After 10 h, a time similar to previous
studies (Schjenken et al., 2015), mice were killed by cervical
dislocation and uteri dissected. Each horn was flushed with
250 µl RPMI with 0.1%BSA, the top quarter of one horn was
immediately frozen in liquid nitrogen for later RNA extraction,
and the remaining uterine tissue was frozen in OCT medium for
immunohistochemistry.
In the second experiment, adult virgin females (Rln−/− and
Rln+/+) were mated overnight with either Rln−/− or Rln+/+
males of proven fertility. After checking for copulatory plugs the
following morning, the females were killed between 10:00 and
12:00 h by cervical dislocation. Uterine lavage and uterine tissue
were collected as above.
Additionally, adult male wild type mice (Dummerstorf DUK
strain) were euthanized as above and testes, epididymides,
seminal vesicles, vas deferens, prostate, preputial, and
coagulating glands were dissected for extraction of RNA
(see below). Also testes and epididymides from adult sibling
wild type (+/+) and relaxin deleted (−/−) male mice were
similarly processed. Animal experimentation was approved by
the Animal Ethics Committee of the University of Adelaide
(approval number S-042-2007) or by the Animal Ethics
Committee of Mecklenburg-Vorpommern, Germany (no.
LALLF M-V/TSD/7221.3-1.1-033/06).
Analysis of Uterine Tissue
Rat anti-mouse mAb hybridoma supernatants recognizing CD45
(TIB122; reactive with all leukocytes) and Ly-6G (RB6-8C5;
reactive with neutrophils) were used to determine the density
and distribution of leukocytes within the mouse endometrium
(Supplementary Table 1). Cross-sections of uterine tissue (7 µm)
were cut from OCT-embedded frozen uterus, air-dried, and
stored at −80◦C with silica gel (Ajax Finechem, Auburn, NSW,
Australia) until staining was performed. Sections of uterine
tissue were fixed in 96% ethanol for 10 min at 4◦C, then
rinsed three times in PBS. Non-specific binding was blocked by
incubation with 1% (w/v) BSA in PBS for 2min. Duplicate non-
serial sections were incubated with neat hybridoma supernatant
(+10% normal mouse serum, NMS) at 4◦C overnight. Negative
control sections were incubated with dilution buffer alone (PBS
with 1% BSA and 10% NMS). All sections were washed and
then incubated with biotinylated rabbit anti-rat secondary Ab
(1:300 in dilution buffer; Dako Corporation, Carpinteria, CA)
at 4◦C for 2 h. The tissue sections were washed again in PBS,
and incubated with Avidin-HRP conjugate (1:400 in dilution
buffer; Dako Corporation) at 4◦C for 2 h. SigmaFAST DAB
tablet set (diaminobenzindine tetrachloride (0.7mg/ml) and urea
hydrogen peroxide (0.67 mg.ml); Sigma-Aldrich, St. Louis, MO)
was employed to develop HRP staining followed by incubation
for 10min at room temperature. Sections were counterstained
with hematoxylin (Sigma-Aldrich) and dehydrated in two
changes of absolute ethanol, cleared in two changes of Safsolvent
(Ajax Finechem), and mounted in Depex (BDH Laboratory
Supplies, Toronto, ON, Canada). Video image analysis (VIA)
software (Video Pro 32; Leading Edge, Blackwood, SA, Australia)
was used to quantify the density of positive (DAB) staining in the
uterine tissue sections. Prior to each session of data collection, the
VIA system was calibrated using a standard field of tissue. The
mean area of positive staining (% positivity) was quantified in 10
medium-power fields (x20 objective) from each horn in two non-
serial sections of endometrial stroma. Data were expressed as a
percentage calculated as (mean area of DAB stain/[mean area of
hematoxylin+ DAB stain]× 100).
RNA Analysis
RNA was prepared from uterine tissue and from various
male organs as previously (Heng et al., 2012), using the
Trizol reagent (Life Technologies, Mulgrave, Australia) and
subsequently subjected to treatment with RNAse-free DNAse
(TURBO DNA-freeTM; Life Technologies) according to the
manufacturer’s instructions. Because it proved difficult to process
prostate tissue without incurring significant RNA degradation,
RNA fromCD1 and CD57BL/6mouse prostate was also obtained
from Amsbio (Abingdon, UK). cDNA was prepared from 3 µg
total RNA per sample using oligo(dT) priming and Superscript II
(Life Technologies) reverse transcriptase, again according to the
manufacturer’s instructions. Quantitative real-time PCR (qRT-
PCR) was carried out using a Corbett Rotor-Gene 3000 (Qiagen,
Melbourne, VIC, Australia) and the ExTaq Sybr-Green pre-mix
(Takara, Shiga, Japan), with oligonucleotide primers and PCR
conditions as listed in Supplementary Table 2. Primer pairs were
designed using Primer 3 software to span at least one exon-
exon boundary. Transcript levels were normalized against the
ribosomal protein transcript S27a (Rps27a; Lee et al., 2002).
Results were analyzed using Q-gene96 software (Muller et al.,
2002). PCR products were validated by inspection of melt curves,
as well as electrophoresis and sequencing of the final products
for all genes. Additionally, RNA extracted in experiment two was
subjected to Gene Signature Low Density Array RT-PCR analysis
(LDAP; Life Technologies) using the Mouse Immune array
(#4367786) exactly following the manufacturer’s instructions,
and employing an Applied Biosystems 7900HT analysis system.
With this microfluidics system, 96 independent immune-related
mouse gene transcripts could be analyzed with high fidelity
from eight uterine RNA samples originating from Rln−/− female
mice mated with Rln−/− males (n = 4) or Rln+/+ males (n
= 4). Samples were selected on the basis of RNA integrity and
quality, assessed by UV spectrophotometry (A260/A280 ratio
> 2) and gel electrophoresis (28S/18S integrity) as well as by
high consistency in the CT-values for housekeeping transcripts.
Results were normalized against internal Gapdh, Actb, and Rn18s
ribosomal RNA housekeeping targets.
Analysis of Uterine Lavage
All uterine lavage samples were frozen at −80◦C until analysis.
For experiment 1, only CXCL1 (mouse KC) was assessed using a
commercial ELISA kit (DY453; R&D Systems; Minneapolis, MN)
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exactly as per the manufacturer’s instructions. For experiment
2, all samples were analyzed for cytokine and chemokine
content using the Luminex multiplex system (Milliplex MAP kit,
mouse cytokine/chemokine catalog #MPXMCYTO-70K; Merck-
Millipore, Kilsyth, VIC, Australia) with a panel of 15 targets
(CSF1, CSF2, CSF3, IL1A, IL1B, IL6, IL10, CXCL1, CXCL10,
LIF, CCL2, CCL3, CCL4, CCL5, and TNFα). The manufacturer’s
protocol was followed precisely.
Statistics
All data sets were analyzed by ANOVA followed by Neumann-
Keuls post-hoc test or by Student’s t-test to check individual
comparisons. Because of marked skewness in the data, the
Luminex cytokine data were log transformed prior to statistical
analysis. p < 0.05 was considered significant.
RESULTS
Expression of Relaxin in the Male
Reproductive Tract and Impact of Relaxin
Gene Deletion
In most mammals the likely source of seminal relaxin is probably
the prostate and /or the seminal vesicles. In mice, based on their
expression of relaxin mRNA, the main sources would appear
to be in descending order: epididymis, prostate, testis, then
seminal vesicles and vas deferens, with coagulating and preputial
glands having only trace amounts of specific mRNA (Figure 1).
Prostate mRNA proved to be variable with expression of Rln
transcripts possibly depending on mouse strain. Our results are
very similar to those presented by Ganesan et al. (2009), who also
indicated low but variable expression of prostate relaxin mRNA
for C57BL/6 mice. TGFß1, TGFß2, and TGFß3 are suggested
to be amongst the major immunomodulatory components of
seminal plasma (Robertson et al., 2002) and are also expressed
in the organs of the male tract with TGFß1 and TGFß2 being
quantitatively more important than TGFß3 (Robertson et al.,
2002). In order to determine whether the lack of relaxin in
male organs might be influencing the expression of TGFß and
hence indirectly affecting the immunomodulatory properties
of seminal plasma, TGFß gene expression was compared in
the epididymides and testes, as the main sources of male
relaxin, from relaxin knockout and sibling wild type mice
(Supplementary Figure 1). For none of the TGFß subtypes was
any difference noted.
Effect of Exogenous Recombinant Human
Relaxin on Uterine CXCL1 Synthesis In vivo
In the first experiment, exogenous rhRLN or vehicle was
injected into the lumen of both left and right uterine horns
in healthy virgin adult estrous Rln+/+ mice, i.e., mimicking
the expected time of natural insemination. Ten hours later
mice were sacrificed, uterine flushings collected and uterine
tissue frozen in liquid nitrogen for later preparation of RNA
for qRT-PCR analysis (left horns), or frozen in OCT medium
for immunohistochemical evaluation (right horns). qRT-PCR
analysis was carried out to quantify mRNA for Cxcl1, which
FIGURE 1 | Real-time qRT-PCR quantification of Rln transcript levels in RNA
extracted from testis (T), epididymis (E), vas deferens (VD), prostate (P),
seminal vesicles (SV), coagulating glands (CG), and preputial glands (PG) from
male wild type mice. Note that whereas most tissues derived from the DUK
strain, prostate additionally derived from CD1 and CD57/Black 6 strains. (A)
Example of PCR products from individual tissues following limited PCR cycles
(this included prostate from DUK mice). (B) Relative transcript level normalized
against Rps27a (mean ± SEM; n = 3–4 individuals per tissue).
encodes a typical pro-inflammatory cytokine, CXCL1 (mouse
KC), which is known to be secreted from the mouse uterine
epithelium (Robertson et al., 1998; Wood et al., 1999; Orsi
et al., 2007). Moreover, this cytokine was selected for this
pilot study as its functional equivalent in humans, IL-8, is
secreted in response to relaxin by extraplacental chorionic
cytotrophoblast (Bryant-Greenwood et al., 2009). In 50% of
the mice Cxcl1 mRNA appeared to be considerably altered
by the relaxin treatment (Figure 2A), though some animals
did not appear to respond. Evaluation of uterine flushings by
cytokine-specific ELISA supports the gene expression results,
with a similar increase in CXCL1 peptide secreted into the
uterine lumen (Figure 2B). However, these differences were
not statistically significant, largely due to some individual
animals not responding to the treatment. In support of this
interpretation, a strong correlation between Cxcl1 mRNA and
CXCL1 peptide from the same individuals is evident (Figure 2C).
Immunohistochemical examination of uterine sections using two
different antibodies to detect all leukocytes (CD45; TIB122)
or neutrophils (RB6-8C5), showed no significant differences
between treatment groups (Supplementary Figure 2D), implying
that relaxin alone injected into the uterus did not lead to marked
recruitment of immune cells. This did not differ even when
comparing responders and non-responders (not shown). Similar
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FIGURE 2 | Effect of recombinant human relaxin (rhRLN) injected into the uterine horns at estrus on uterine Cxcl1 mRNA expression assessed by qRT-PCR (A), and
CXCL1 secretion into uterine luminal fluid assessed by specific ELISA (B), and the correlation between these parameters for individual mice (C). Data are mean
± SEM (n = 7–8 per category). In panel (C), symbols indicate data from mice both receiving or not rhRLN.
results were obtained using qRT-PCR to evaluate the expression
of PtprcmRNA encoding CD45 (Supplementary Figure 2C).
Effect of Endogenous Relaxin Delivered by
Natural Insemination on the Mouse Uterus
In vivo
In the second set of experiments, we investigated the effect
of genetic relaxin deficiency in either male semen and
seminal fluid or the female reproductive tract. Wild-type
female mice (Rln+/+), expressing ovarian relaxin, as well as
Rln−/− female mice were mated with either Rln+/+ or Rln−/−
males. These mating combinations provided the opportunity
to evaluate the relative contributions of both seminal relaxin
and endogenous ovarian relaxin in regulating the female post-
mating cytokine response. Unlike the first experiment, analysis
has made use of a more unbiased approach using LDAP
cytokine mRNA arrays as well as cytokine/chemokine Luminex
immunoarrays.
Comparing Rln−/− and Rln+/+ Males on a
Rln−/− Female Background
The preliminary cytokine mRNA LDAP analysis was restricted
to comparing gene transcripts which were either up- or down-
regulated when uterine tissue was derived from Rln−/− females
that were mated with Rln+/+ compared with Rln−/− males
(Table 1). Only 14 of the 96 cytokine-related gene transcripts
represented in these arrays were altered in their expression.
The array data suggested that several cytokines and chemokines
involved in regulating the inflammatory response may be
expressed at higher levels in Rln−/− females mated with Rln−/−
males compared with Rln+/+ males (including Ccl2, Csf1,
Csf3, Cxcl10, and Il6, all p < 0.05). This initial analysis was
used to identify potential candidates for in-depth qRT-PCR
measurement.
Subsequent qRT-PCR analysis of these apparently regulated
genes (Figure 3), partly confirmed the LDAP array results for
TABLE 1 | Gene transcripts significantly altered in Rln−/− females when mated
with Rln+/+ compared to Rln−/− males using the mouse cytokine LDAP array.
Gene Names and features Up/down Fold
change
Significance
Agtr2 Angiotensin II receptor, type 2 Up 2.2 p = 0.01
Bcl2 Anti-apoptotic regulator Up 1.6 p = 0.04
Ccl2 MCP1 Down 0.1 p = 0.01
Ccl3 MIP-1α (Down)1 0.3 p = 0.07
Cd80 T cell modulator Down 0.4 p = 0.04
Csf1 M-CSF Down 0.6 p = 0.01
Csf3 G-CSF Down 0.1 p = 0.01
Cxcl10 IP-10 Down 0.2 p = 0.02
Ece1 Endothelin-converting enzyme 1 Down 0.6 p = 0.02
Il18 Interleukin 18 (Up) 1.7 p = 0.07
Il6 Interleukin 6 Down 0.1 p = 0.03
Ptgs2 Cyclooxygenase type 2 (Down) 0.2 p = 0.10
Ptprc CD45 Up 1.6 p = 0.01
Smad3 Downstream TGFß signaling Up 1.5 p = 0.02
1parentheses indicate that the fold-change was significant at the p < 0.1 but not the p <
0.05 level.
Ccl2, Cd80, IL6, and Ptgs2, in that these four gene transcripts also
showed a similar trend toward reduction caused by mating the
Rln−/− females with Rln+/+ males, compared to Rln−/− males,
though this was just not statistically significant. Measurement
of cytokines in the uterine lavage from these matings showed a
significant reduction on mating to Rln +/+ males only for CCL5,
though similar trends were apparent also for CSF1 and IL1b
(Figure 4).
Comparing Rln−/− and Rln+/+ Males on a
Rln+/+ Female Background
Uterine RNA was recovered from Rln+/+ females mated with
both Rln−/− and Rln+/+ males and analyzed by qRT-PCR, to
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FIGURE 3 | Real-time qRT-PCR quantification of specific transcript levels in RNA extracted from the individual uteri of different mating combinations utilizing Rln+/+
and Rln−/− male and female mice, as indicated. Data are mean ± SEM. p-values indicating effect of treatment group on cytokine mRNA concentration are shown.
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FIGURE 4 | Luminex multiplex analysis of individual cytokines and chemokines present in uterine lavage fluid derived from different mating combinations utilizing
Rln+/+ and Rln−/− male and female mice, as indicated. Data were log transformed prior to analysis, and are given as mean ± SEM. p-values indicating effect of
treatment group on cytokine content are shown.
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evaluate whether similar changes to those above were observed
when female relaxin was intact (Figure 3). In this comparison,
the absence of male relaxin caused a different shift in the pattern
of response, with substantially reduced uterine expression of
several cytokine and chemokine genes including Ccl2, Csf3,
Cxcl10, and Cxcl1 after Rln+/+ females were mated with Rln−/−
compared with Rln+/+ males. Additionally, Ptprc, encoding the
leukocyte common antigen CD45, Cd80, Ptgs2, Smad3, and Bcl2
were similarly all down-regulated in the absence of male relaxin.
Uterine flushings from the same mating combinations
(Rln+/+ females vs. Rln−/− or Rln +/+ males; Figure 4) were
analyzed by the Luminex cytokine system. Whilst for most
products individual variation was too high to yield statistical
significance, for both CSF3 and CXCL10, there was a significant
(p < 0.05) reduction upon mating with Rln−/− males, reflecting
that seen at the mRNA level, as also a strong trend to reduction
for CXCL1 (p= 0.08).
Comparing Rln−/− and Rln+/+ Females on
a Rln+/+ Male Background
Comparison of uterine gene expression in Rln−/− and Rln+/+
females after mating with Rln+/+ males also showed substantial
effects for several gene transcripts (Figure 3), indicating that
the presence or absence of relaxin in the female mice was not
without influence. In Rln−/− females, a substantial reduction in
expression of cytokine and chemokine genes Ccl2, Csf3, Cxcl1,
Cxcl10, and Il6 was evident (Figure 3). This was accompanied by
significantly diminished expression of Cd80, Ptprc (Cd45), Ptgs2,
and Smad3 (Figure 3). No significant differences for this mating
combination were revealed at the level of cytokine peptides
(Figure 4).
Other Mating Combinations
As might be anticipated, when complete absence of relaxin in
both males and females is compared to full wild type matings,
then significant decreases in uterine mRNA in the Rln−/−
females are observed for Csf3, Cxcl10, IL6, Cxcl1, Ptgs2, Ptprc
(Cd45), and Smad3 (Figure 3), i.e., essentially similar to the
effects seen comparing female Rln−/− with female Rln+/+ both
mated with Rln+/+ males. Also as for this mating combination,
no effects were evident at the level of peptides in the uterine
washings (Figure 4). Only for Bcl2 mRNA was there any
significant difference at the transcript level for the reciprocal
matings female Rln−/− with male Rln+/+ vs. female Rln+/+
with male Rln −/− (Figure 3), and at the level of peptides in the
uterine lavage fluid, only CSF3 indicated a significant difference
(Figure 4).
As controls, the transcript levels for relaxin itself as well as for
its specific receptor RXFP1 were also measured. Other than the
absence of relaxin in the uteri of Rln−/− mice, no differences in
expression were evident (Supplementary Figures 2E,F).
DISCUSSION
It is not possible directly to assess relaxin in mouse seminal
fluid since electroejaculatory techniques are not well developed
for this species, and the usual method of using uterine lavage
following mating is logically prohibited since relaxin may be
secreted or metabolized within the female tract. Therefore, we
made an exhaustive RT-PCR analysis of those male organs
likely to be contributing most to seminal fluid. The mammalian
ejaculate is not uniform but rather comprises different secretory
elements delivered sequentially to achieve different roles. The
initial ejaculate comprises largely epididymal fluid containing
sperm and some testicular contribution, together with some
secretion from the prostate and preputial glands (Rodríguez-
Martínez et al., 2011). This is followed by increasing amounts
of prostatic and seminal vesicle fluid, which together alter the
physical properties of the ejaculate. Last in rodents are the
secretions of the coagulating gland. The observation that relaxin
is a product mostly of the epididymis, followed by the prostate
and testis in mice, is therefore fully compatible with the view that
the initial ejaculate may be the most important contributor to
the immunomodulatory dialog between seminal plasma and the
uterus. Whilst, it is proposed that the TGFß family of peptides
may be amongst the most important components of seminal
plasma in the context of immune adjustment of the uterus (Esche
et al., 2005), we have shown here that none of the TGFß subtype
transcripts appear to be altered in the testis and epididymis,
representative of the main relevant relaxin-producing organs of
the male system in homozygous relaxin knockout mice. Since
relaxin in the male is rather a paracrine/autocrine than an
endocrine acting hormone, it is unlikely that TGFβwill be altered
in those tissues not expressing relaxin. Taken together these
findings strongly support the view that the effects observed in the
present studies are due to relaxin, probably of epididymal and/or
prostatic origin, present in murine seminal fluid at ejaculation,
although a role for spermatozoa as passive carriers of relaxin
cannot be excluded.
The principal aim of this study was to define the contribution
of male relaxin in eliciting expression of cytokines and
chemokines in the uterine post-mating cytokine response. Using
two complimentary strategies involving either administration of
exogenous relaxin or analysis of the effects of genetic relaxin
deficiency, we show herein that male relaxin is a contributing
factor in regulating uterine synthesis particularly of the cytokines
CCL2, CSF3, CXCL1, and CXCL10 during the 10 h period
following mating, and also of the downstream effectors PTGS2,
and SMAD3. These changes are also associated with an increase
due to male relaxin of uterine mRNA for the pan-leukocyte
antigen PTPRC (CD45), at least in the cross-mating experiment,
implying that there may indeed be a net increase in uterine
leukocytes following mating with Rln+/+ males. The apparent
difference for CD45 between the LDAP results (Table 1; up-
regulated by relaxin on a Rln−/− female background) and the
qRT-PCR results (Figure 3; no change for the same mating
combination) may be due to the larger number of RNA samples
used in the latter analysis.
CSF3 and CXCL1 are identified as regulators of neutrophil
recruitment and activation, while CXCL10 targets monocyte
macrophages, dendritic cells, and lymphocytes (Esche et al.,
2005). Neutrophils, macrophages, and dendritic cells are
prevalent amongst the leukocytes infiltrating the uterine stroma
and lumen after semen deposition (McMaster et al., 1992;
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Robertson et al., 1998), and these cells have key roles in the
immune adaptations as well as structural changes required for
uterine receptivity at implantation (Esche et al., 2005; Plaks et al.,
2008; Moldenhauer et al., 2009).
In the first approach used, recombinant human relaxin was
injected directly into the uteri of estrous wild-type female mice, at
a dose presenting moderately supraphysiological concentrations
of relaxin to the luminal surface of the endometrium. Ten hours
later, animals were sacrificed, uteri flushed, and tissues collected
for qRT-PCR and immunohistochemistry. After this time period
in these cycling virgin mice only persistent, non-acute effects of
the administered relaxin are likely to be observed. It is therefore
not unexpected that some animals might indicate no effect at this
time-point. CXCL1 (mouse KC) was chosen as indicator, since
it has been previously shown to be a reliable marker of specific
uterine epithelial secretion in the mouse (Orsi et al., 2007) and is
known to be elevated after mating (Wood et al., 1999). Moreover,
CXCL1 is considered to be a functional equivalent to IL8 in the
human female tract, and IL8 expression has been shown to be
stimulated by relaxin both in human cytotrophoblast cells and
decidual macrophages (Horton et al., 2011, 2012), as well as to
be induced by seminal fluid in the human cervix after coitus
(Sharkey et al., 2012b). Although, the large differences between
relaxin stimulation and vehicle, both for mRNA and peptide
expression in this experiment, failed to reach significance due
to apparent non-responder mice, the significant correlation (p <
0.001) between peptide and mRNA expression strongly implies
that the variance in this model is not of a technical nature,
but is due to the biological variability in mouse responsiveness.
Histological examination indicated no obvious morphological
correlates possibly indicative of infection. Moreover, in this
experiment, no differences were noted in terms of leukocyte
recruitment to the uterus as assessed by immunohistochemistry
and qRT-PCR (Supplementary Figure 2), though such methods
may not be sufficiently sensitive at this time-point to identify real
changes in leukocyte numbers.
Following this preliminary study which indicated that pure
exogenous relaxin introduced into the uterine lumen at estrous
can have an effect on the uterine cytokine response, the second
experiment was designed to test the effect of seminal relaxin
in the context of natural mating. It is important to note here
that the mRNA measured by the LDAP array and by individual
qRT-PCR reflected all components of the uterus, including
myometrial, epithelial, and stromal cells, as well as resident
leukocytes. In contrast, the proteins detected in the uterine
lavage are presumably secreted by the uterine epithelium and
possibly resident leukocytes, which in the period after mating
are abundant in the endometrial tissue subjacent to the epithelial
surface, as well as within the uterine lumen (McMaster et al.,
1992; Robertson et al., 1998). Thus, they represent a subset
of the total proteome of the endometrium and also may be
lacking components secreted acutely and subsequently degraded
or resorbed.
In addition to the effects of male relaxin discussed above,
significant effects of endogenous female relaxin were also evident
in experiments comparing Rln−/− females with Rln+/+ females.
Mating with wild type (Rln+/+) males resulted in a significantly
diminished uterine expression in the absence of endogenous
relaxin of transcripts for Ccl2, Cd80, Csf3, Cxcl1, Cxcl10,
Il6, Ptgs2, Ptprc (CD45), and Smad3. This suggests that pre-
exposure of the female to endogenous relaxin in some way
potentiates the female response to seminal fluid introduced
during mating. This was not reflected in any change in secreted
cytokines at the peptide level (the remaining gene products
were not evaluated). However, since the experimental approach
evaluated only proteins secreted at the apical surface of the
epithelium or by cells within the lumen, but not basally secreted
proteins or stromal cell products, the possibility that more
detailed analysis would reveal protein differences cannot be
discounted.
The effects of female relaxin deficiency were less pronounced
when responses to mating with Rln−/− males were evaluated.
qRT-PCR analysis showed no significant effect of the presence
or not of female relaxin in this context. At the level of uterine
lavage, however, differences were seen for CSF3, CXCL1, and
CCL5, with the presence of relaxin in the female leading to a
diminution in these peptides. One interpretation of this data,
taken together with data frommatings with Rln+/+ males, is that
the potentiating effect of relaxin on female tract responsiveness
particularly affects the response to the relaxin component of the
seminal fluid signaling activity. Whilst, it could be expected that
chronic relaxin absence in null mutant females might lead to
a change in the expression of the relaxin receptor, RXFP1, or
otherwise alter the relaxin signaling cascade, no differences in
Rxfp1 mRNA expression were observed (Supplementary Figure
2), as had been previously reported for Rln−/− mice (Siebel et al.,
2003).
When the effects at the mRNA level of male Rln−/− mice
are compared with those of male Rln+/+ mice after mating to
Rln−/− females, as measured by individual qRT-PCR, there is no
significant change for any transcript when measured using qRT-
PCR. This thus differs from the LDAP array analysis (Table 1),
where altogether 14 transcripts appeared to be significantly either
up- or down-regulated. Whereas, the LDAP arrays were limited
to four individuals from each mating combination with the
Rln−/− females, the subsequent individual qRT-PCR analyses
included all mating combinations with between five and nine
uterine samples, each from a separate female, included in each
combination. Thus, the latter analysis inherently comprises more
potential for biological variation. At the peptide level for the
mating combinations involving Rln−/− females, there is also
only a significant down-regulation due to male relaxin observed
for CCL5. Thus, in the absence of any female relaxin, seminal
relaxin either has no significant effect or acts to down-regulate
the pro-inflammatory cytokine network.
This is quite different where the female mice express
endogenous relaxin. On the Rln+/+ female background, mating
with Rln+/+ males, as opposed to Rln−/− males, leads to
the specific up-regulation of several transcripts and/or secreted
peptides representing the pro-inflammatory cytokine network
(specifically Ccl2, Cd80, Csf3, Cxcl10, Cxcl1, Ptgs2, Ptprc (Cd45),
Smad3, Bcl2). No gene products are significantly down-regulated
in this mating combination. Importantly, for Csf3 and Cxcl10
gene products the up-regulation is significant at both mRNA and
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secreted peptide levels, providing confidence in the interpretation
that these factors are indeed regulated by seminal relaxin.
There is considerable evidence to show that one of the main
components of mouse seminal plasma, TGFß, has a significant
influence on the immune competence of the inseminated uterus
(Rodríguez-Martínez et al., 2011). There is no evidence, however,
to suggest that TGFß production or seminal vesicle function
is impaired in the Rln−/− males (Samuel et al., 2003; see also
Supplementary Figure 1), nor does there appear to be any impact
of the mutation on breeding performance parameters (Zhao
et al., 1999; Glynn and Ivell, unpublished). Thus, it is interesting
to note that amongst the cytokines specifically affected by the
male relaxin gene knockout, the specific downstream TGFß
effectors SMAD3 and PTPRC (CD45) are up-regulated, as is also
the inducible prostaglandin synthase, PTGS2. The implicated
cytokines have also recently been shown to be part of the TLR4
signaling cascade in the mouse uterus responsive to seminal fluid
(Schjenken et al., 2015). It therefore seems likely that male relaxin
is working additively with TGFß, to induce immune tolerance in
the female in preparation for implantation. This is also supported
by the specific up-regulation by mating with the Rln+/+ males of
Cxcl10 and the tolerogenic dendritic cell marker Cd80.
It has been shown that seminal plasma per-se, and in
particular the TGFß component of this, are important for the
recruitment of leukocytes to the uterus and their involvement
in the development of immune tolerance to potential paternal
alloantigens expressed by the fetus (Robertson et al., 2006;
Robertson, 2007). Some of these experiments made use of
relatively gross manipulations of seminal plasma, for example,
mating with animals which had had their seminal vesicles
surgically removed (Johansson et al., 2004). In the experiment
described here all of the components of seminal plasma, except
for seminal relaxin, are unchanged. Given the known redundancy
amongst the broad panel of chemokines induced in the uterus
by seminal fluid (McMaster et al., 1992; Robertson et al., 1998),
it is possible that the moderate changes in chemokine and
cytokine levels reported in this study might be insufficient to
cause major alterations in the relative abundance of different
recruited leukocytes in the endometrium. Thus, in the first
experiment, where recombinant relaxin was introduced into
the uteri of wild-type female mice, we failed to detect any
impact on recruited leukocytes, using immunohistochemistry
or qRT-PCR. Nevertheless, in the second study using different
matings of Rln−/− mice, uterine mRNA for the pan-leukocyte
antigen CD45, as also the dendritic cell marker CD80, were
indeed significantly altered in direct association with the changes
in specific cytokine transcripts. Future studies to evaluate the
precise phenotypes and functional competence of leukocytes in
activities including antigen presentation and fate determination
of activated T cells would be warranted. It is relevant that
previous studies in relaxin-deficient mice have not included
analysis of allogeneic matings, where fetal-maternal MHC
disparity might reveal a more profound role in maternal immune
regulation than is suggested by existing reports.
One of the more interesting findings was the observation that
the effect of seminal relaxin was markedly different on a female
Rln−/− compared to a female Rln+/+ background. The relaxin
contributed by the female may act in some way to “prime” or
sensitize the immune response within the uterus. This female
effect may also be simply additive or synergistic in regard to
effects of relaxin in the female tract, whereby the uterine lumen
could be considered as an independent compartment separated
from the endometrium by the tight junctions of the luminal
epithelium (Robertson et al., 1997; Wira et al., 2005). Female
relaxin, which at the time of insemination in rodents is secreted
both by granulosa cells of pre-ovulatory follicles as well as by
the corpus luteum, most likely uses a vascular route to target
receptors on endometrial stromal and vascular cells, as well as
the myometrium, and possibly also the baso-lateral compartment
of the luminal epithelium. In female reproductive physiology,
relaxin has been shown to influence particularly the stromal cells
to induce decidualization, and later to support angiogenesis and
vasodilation (Ivell and Einspanier, 2002; Goldsmith et al., 2004),
besides synergizing with estrogen to cause the typical uterine
edema observed at implantation (Pillai et al., 1999). Thus, at
estrus ovarian relaxin is likely already activating specific receptors
within the uterus, at the time when seminal relaxin is added by
insemination.
Finally, there is the question of whether, besides activating
cytokines of epithelial origin, relaxin is also able to stimulate
immune cells directly. It has been long established that
relaxin is able to stimulate PKA-dependent pathways within
human monocytes (Bartsch et al., 2001), directly inducing
effects on adhesion and migration that might facilitate
monocyte/macrophage recruitment in an inflammatory response
(Figueiredo et al., 2006). Moreover, relaxin has been shown in
vitro to promote the formation of Th1 cells, which produce the
anti-inflammatory cytokine IFNγ, rather than Th2 cells (Piccinni
et al., 1999). However, a skewing in favor of Th1 cells would seem
at odds with emerging data that Treg cells are the predominant
phenotype elicited by seminal fluid exposure (Robertson et al.,
2009), so future experiments in relaxin null mutant mice are
required to investigate this.
In conclusion, these studies in mice show for the first time
that there is an important role for relaxin of male origin to act in
concert with other proinflammatory agents in seminal fluid, such
as TGFß, in order to initiate the cytokine response underpinning
maternal immune adaptation for embryo implantation and
development. Furthermore, as a corollary, female relaxin may
act to sensitize the uterus to such effects, since both male
and female relaxin appear to be required for maximal cytokine
expression and effect. However, the fact that Rln−/− mice are
essentially fertile shows that there is a degree of redundancy in
such informational processing. These findings are of necessity
preliminary and will require more intensive study in the future,
making use of other time-points and possibly including animals
with inactivated relaxin receptors.
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